Tafolecimab, a novel potential long-acting PCSK9 monoclonal antibody: efficacy and safety in healthy and hypercholesterolemia subjects
29 August 2020 (00:00 - 00:00)
Organised by:
About the speaker
Peking University First Hospital, Beijing (China)
56 More presentations in this session
Doctor C. Becker (Wuppertal, DE)
Doctor S. Frechen (Leverkusen, DE)
Doctor D. Radenkovic (Greater London, GB)
Doctor P. Sulzgruber (Krems an der Donau, AT)
Access the full session
The Event
ESC Congress 2020
29 August - 1 September 2020
You may be interested in
Congress Presentation
